SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-031497
Filing Date
2024-03-14
Accepted
2024-03-14 16:15:50
Documents
76
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tern-20231231.htm   iXBRL 10-K 3034104
2 EX-4.3 tern-ex4_3.htm EX-4.3 43078
3 EX-10.6 tern-ex10_6.htm EX-10.6 110590
4 EX-10.8 tern-ex10_8.htm EX-10.8 110870
5 EX-10.9 tern-ex10_9.htm EX-10.9 18284
6 EX-10.10 tern-ex10_10.htm EX-10.10 110561
7 EX-23.1 tern-ex23_1.htm EX-23.1 4564
8 EX-31.1 tern-ex31_1.htm EX-31.1 15967
9 EX-31.2 tern-ex31_2.htm EX-31.2 15739
10 EX-32.1 tern-ex32_1.htm EX-32.1 8660
11 EX-32.2 tern-ex32_2.htm EX-32.2 8673
12 GRAPHIC img255905566_0.jpg GRAPHIC 36489
13 GRAPHIC img255905566_1.jpg GRAPHIC 36382
  Complete submission text file 0000950170-24-031497.txt   15903689

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tern-20231231.xsd EX-101.SCH 1596730
78 EXTRACTED XBRL INSTANCE DOCUMENT tern-20231231_htm.xml XML 4060310
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39926 | Film No.: 24750345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)